| 摘要 |
<p>The invention is concerned with novel heteroaryl fused cyclic amines of formula (I) wherein A, X<sup>1</sup> to X<sup>3</sup>, Y<sup>1</sup> to Y<sup>3</sup>, Z, R<sup>1</sup>, R<sup>2</sup>, m and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.</p> |
